Shilpa Medicare Stock Screener | Share Price & Fundamental Analysis
SHILPAMED
Pharmaceuticals
Share Price NSE
₹324.80
▼
-4.00 (-1.22%)
Share Price BSE
₹324.45
▼
-4.15 (-1.26%)
Track Shilpa Medicare share price live with TickJournal's free stock screener.
Analyze Shilpa Medicare share price history trends and compare 52-week high low
levels.
Calculate SHILPAMED stock fair value using fundamental analysis and view live share price charts.
Determine Shilpa Medicare share intrinsic value and compare it with current SHILPAMED share price.
Record your Shilpa Medicare trades in TickJournal's free trading journal and track your portfolio performance.
Shilpa Medicare Market Cap
₹6,391.61 Cr.
EPS (TTM)
₹8.04
Dividend Yield
0.15%
Debt to Equity
0.36
SHILPAMED 52 Week High
₹847.75
Shilpa Medicare 52 Week Low
₹267.00
Operating Margin
25.00%
Profit Margin
10.95%
SHILPAMED Revenue (TTM)
₹411.00
EBITDA
₹102.00
Net Income
₹45.00
Total Assets
₹3,311.00
Total Equity
₹2,364.00
Shilpa Medicare Share Price History - Stock Screener Chart
Screen SHILPAMED historical share price movements with interactive charts. Analyze price trends and patterns.
Shilpa Medicare Company Profile - Fundamental Screener
Screen Shilpa Medicare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SHILPAMED shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE790G01031
Shilpa Medicare Balance Sheet Screener
Screen SHILPAMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 3,311 | 3,093 | 2,904 | 2,876 | 2,632 | 1,989 | 1,610 | 1,499 | 1,472 | 931 |
| Current Assets | 986 | 877 | 770 | 887 | 903 | 624 | 545 | 672 | 730 | 354 |
| Fixed Assets | 1,418 | 1,385 | 1,368 | 1,342 | 1,111 | 650 | 558 | 534 | 492 | 393 |
| Liabilities | ||||||||||
| Total Liabilities | 3,311 | 3,093 | 2,904 | 2,876 | 2,632 | 1,989 | 1,610 | 1,499 | 1,472 | 931 |
| Current Liabilities | 273 | 600 | 345 | 453 | 561 | 257 | 167 | 154 | 251 | 67 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,364 | 1,800 | 1,774 | 1,811 | 1,468 | 1,322 | 1,190 | 1,080 | 984 | 642 |
| Share Capital | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | 2,363 | 1,800 | 1,775 | 1,814 | 1,471 | 1,321 | 1,189 | 1,077 | 979 | 632 |
Shilpa Medicare Income Statement Screener - Profit & Revenue Analysis
Screen Shilpa Medicare income statement and profit fundamentals.
Analyze SHILPAMED quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Shilpa Medicare share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 411 | 372 | 328 | 341 | 300 | 302 | 349 | 321 | 266 | 262 | 315 | 289 | 346 | 269 | 267 |
| Expenses | 309 | 262 | 231 | 282 | 222 | 223 | 258 | 239 | 227 | 214 | 255 | 222 | 268 | 241 | 253 |
| EBITDA | 102 | 110 | 97 | 59 | 79 | 80 | 91 | 82 | 39 | 48 | 60 | 67 | 78 | 28 | 14 |
| Operating Profit % | 25.00% | 29.00% | 28.00% | 15.00% | 24.00% | 24.00% | 25.00% | 25.00% | 14.00% | 18.00% | 19.00% | 23.00% | 21.00% | 8.00% | 4.00% |
| Depreciation | 30 | 30 | 29 | 29 | 27 | 27 | 28 | 29 | 26 | 27 | 28 | 27 | 22 | 22 | 23 |
| Interest | 11 | 16 | 19 | 15 | 24 | 24 | 26 | 12 | 18 | 18 | 23 | 26 | 9 | 10 | 14 |
| Profit Before Tax | 61 | 64 | 50 | 15 | 28 | 29 | 37 | 42 | -4 | 3 | 9 | 14 | 46 | -4 | -22 |
| Tax | 16 | 20 | 3 | 1 | 3 | 15 | 19 | 10 | 4 | 2 | 8 | 10 | 17 | -6 | -4 |
| Net Profit | 45 | 44 | 47 | 15 | 25 | 14 | 18 | 32 | -8 | 1 | 2 | 5 | 30 | 2 | -19 |
| EPS | 2.36 | 5.50 | 4.79 | 1.48 | 2.82 | 1.46 | 1.83 | 3.25 | -0.93 | 0.14 | 0.19 | 0.53 | 3.40 | 0.10 | -2.15 |
Shilpa Medicare Cash Flow Screener - Liquidity Fundamentals
Screen SHILPAMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 132 | 137 | 180 | 105 | 47 | 124 | 147 | 45 | 38 | 129 |
| Investing Activities | -198 | -171 | -232 | -286 | -404 | -290 | -196 | -10 | -257 | -106 |
| Financing Activities | 63 | 47 | 46 | 83 | 436 | 176 | 10 | -61 | 313 | -20 |
| Net Cash Flow | -3 | 13 | -7 | -98 | 79 | 10 | -40 | -26 | 93 | 3 |
Shilpa Medicare Shareholding Pattern Screener
See Shilpa Medicare shareholding pattern with promoter, FII, and DII holdings.
Check Shilpa Medicare promoter holding and ownership changes for SHILPAMED on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Apr | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.23% | 44.23% | 44.23% | 40.13% | 50.01% | 44.39% | 44.39% | 44.33% |
| FII Holding | 10.97% | 11.20% | 10.92% | 10.97% | 0.00% | 0.00% | 9.08% | 9.58% |
| DII Holding | 7.55% | 7.46% | 7.67% | 8.33% | 1.59% | 6.13% | 7.61% | 8.18% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.43% | 23.21% | 23.34% | 27.80% | 27.64% | 24.54% | 24.69% | 23.94% |
| Other Holding | 12.83% | 13.90% | 13.84% | 12.76% | 20.75% | 24.94% | 14.23% | 13.96% |
| Shareholder Count | 50,108 | 48,636 | 52,065 | 53,799 | 44,793 | 44,809 | 41,072 | 42,784 |
Shilpa Medicare Share Dividend Screener - Share Yield Analysis
Check Shilpa Medicare dividend history with payout and yield data.
View Shilpa Medicare dividend details including ex-dates and amounts for SHILPAMED stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.00 | 0.31% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹1.10 | 0.96% |
| 2021-March | ₹1.10 | 0.55% |
| 2020-March | ₹1.10 | 0.66% |
| 2019-March | ₹1.00 | 0.82% |
| 2018-March | ₹0.70 | 0.41% |
| 2017-March | ₹0.60 | 0.26% |
Shilpa Medicare Stock Index Membership
See which indices include Shilpa Medicare stock.
Check SHILPAMED index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Shilpa Medicare Market Events Screener - Corporate Actions
Get Shilpa Medicare corporate actions including splits, bonuses, and buybacks.
Check Shilpa Medicare stock events that may affect SHILPAMED share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.00 /share | 5.73% | ||
| Dividend | ₹ 1.10 /share | -10.81% | ||
| Annual General Meeting | NA | 26.59% | ||
| Dividend | ₹ 1.10 /share | 7.43% | ||
| Annual General Meeting | NA | -53.04% | ||
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 17.37% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 11.57% |
| 2025-10-03 | 2025-10-03 | Bonus | 1:1 | -4.83% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 2.33% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | 10.39% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 5.08% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 3.95% |
Shilpa Medicare Competitors Screener - Peer Comparison
Screen SHILPAMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 407,287 | 37.56 | 54,729 | 9.71% | 10,980 | 52.49 |
| Divis Laboratories | 163,754 | 66.27 | 9,712 | 18.67% | 2,191 | 48.87 |
| Torrent Pharmaceuticals | 138,018 | 64.55 | 11,539 | 6.99% | 1,911 | 59.36 |
| Cipla | 107,555 | 23.69 | 28,410 | 7.12% | 5,291 | 35.86 |
| Dr Reddys Laboratories | 105,839 | 19.26 | 33,741 | 16.73% | 5,725 | 58.24 |
| Lupin | 100,464 | 23.23 | 22,910 | 13.74% | 3,306 | 56.93 |
| Zydus Life Science | 91,034 | 18.43 | 23,511 | 18.55% | 4,615 | 51.32 |
| Mankind Pharma | 85,058 | 47.59 | 12,744 | 20.90% | 2,007 | 42.02 |
| Aurobindo Pharma | 66,537 | 19.29 | 32,346 | 9.43% | 3,484 | 45.13 |
| Alkem Laboratories | 64,595 | 29.06 | 13,458 | 3.70% | 2,216 | 36.02 |
Shilpa Medicare Company Announcements - News Screener
Screen SHILPAMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-20 | Revised Attachment To Annexure - I. On Execution Of Agreement With NXI Therapeutics AG | View |
| 2026-02-19 | Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015 | View |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-02-12 | Announcement Under Regulation 30 Of The SEBI (LODR) Regulations 2015 | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-02-12 | Announcement Under Regulation 30 (LODR)-Meeting Updates | View |
| 2026-02-12 | Board Meeting Outcome for Outcome Of Board Meeting. | View |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-30 | Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 Of SEBI (LODR) Regulations 2015 | View |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-16 | Assignment Of ESG Rating By SES ESG Research Pvt Ltd | View |
| 2026-01-15 | Intimation Under Regulation 30 Of SEBI(LODR) Regulations 2015 | View |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-30 | Ex-Parte Ad-Interim Injunction Order Regarding Pharmaceutical Drug Product Containing Ruxolitinib And/Or Ruxolitinib Salts API | View |
| 2025-12-26 | Closure of Trading Window | View |
| 2025-12-12 | Intimation Under Of Regulation 30 Of The SEBI(LODR) Regulations | View |
| 2025-11-22 | USFDA Inspection Of Shilpa Medicare Ltd. Unit IV Jadcherla Telangana | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |